查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198540

手術顯微鏡市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Surgical Microscopes Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 121 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，手術顯微鏡市場預計將以 10.89% 的複合年增長率增長。

據世界衛生組織 (WHO) 稱，COVID-19 具有傳染性，許多感染該病毒的人會出現輕度至中度呼吸道疾病。 COVID-19 的高感染率已經並繼續給美國等國家的經濟和醫療系統帶來壓力。 由於實施國家隔離、暫停與其他國家的貿易、旅行限制等，全球主要公司的市值有所下降。 不過，隨著疫苗接種覆蓋率的提高，情況正在逐漸好轉。 由於 COVID-19 相關措施而推遲擇期手術，特別是在 2020 年只允許進行緊急手術，這對手術顯微鏡市場產生了不利影響。 由於資源被用於 COVID-19 患者，大多數心臟手術被取消或推遲。 然而，隨著疫苗接種覆蓋率的提高，進行的手術數量也隨之增加，這對市場產生了重大影響。 在感染率高的地區，手術室臨時改建為輔助呼吸室。 術後恢復室和中級護理病房現在被用作普通重症監護病房以外的護理病房，以管理 COVID-19 患者。 例如，根據《英國外科雜誌》發表的一項研究，2020 年 5 月全球約有 2840 萬次擇期手術因 COVID-19 導致醫院服務中斷長達 12 周而被取消或推遲，這表明負面影響COVID-19 對所研究市場的影響。

市場驅動力包括微創手術的普及、老年人口的增加和慢性病負擔的增加，以及手術顯微鏡的技術進步。

由於出生率下降和預期壽命延長，世界人口正在迅速老齡化。 例如，根據聯合國《2020 年世界人口展望》，65 歲及以上的人口可能會從 2020 年的 9.3% 增長到 2050 年的 16% 以上。 因此，與年齡相關的慢性疾病和相關外科手術變得更加普遍，市場也在不斷擴大。

手術顯微鏡已成為牙科、耳鼻喉科、神經外科、眼科和整容手術中微創外科手術的必備工具。 該產品的技術進步大大提高了視覺、定位、穩定性、尺寸和記錄能力，有助於集成圖像引導顯微鏡系統以獲得更好的結果。

手術顯微鏡提供最佳照明、3D 可視化、通過小入路深度放大手術區域等等。 它還可以通過在執行複雜而冗長的手術時調整姿勢來使外科醫生受益。 預計這些因素將在預測期內推動市場。

但是，在預測期內，缺乏熟練的專業人員和高成本導致的接受度低等因素可能會阻礙市場增長。

手術顯微鏡的市場趨勢

婦科和泌尿科領域有望佔據較大市場份額

COVID-19 大流行對婦科和泌尿科領域產生了重大影響。 大流行極大地影響了外科服務。 根據一項名為 COVIDSurg Collaborative 的研究，2020 年 5 月，由於 COVID-19 流行病，約有 250 萬例良性泌尿外科手術被取消。 然而，擇期手術和急診手術正在恢復，這可能會增加泌尿科和婦科疾病對手術顯微鏡的需求。

手術顯微鏡的應用範圍很廣，但婦科和泌尿科是最常見的應用，因為涉及的程序很多。 泌尿科和婦科疾病在世界範圍內不斷增加，手術顯微鏡存在的意義也越來越大。 例如，尿路感染 (UTI) 是影響所有年齡段人群的最常見的微生物疾病之一。 根據一項名為《泌尿系統感染流行病學：全球負擔》的研究，世界泌尿外科雜誌，2020 年 1 月，大約有 1.5 億人受到社區獲得性尿路感染 (CAUTI) 的影響。 越來越多的目標疾病和越來越複雜的治療導致了先進技術的採用，包括手術顯微鏡。

在婦科和泌尿科實踐中，顯微鏡用於癌症檢測、激光手術和診斷。 結腸鏡檢查或內窺鏡檢查可讓您看到腸道和大腸的內部，從而便於手術。 由於與排便有關的疾病增加，結腸鏡檢查和內窺鏡檢查被廣泛使用，預計將在預測期內推動整個市場。

北美有望在預測期內主導市場

該地區的市場增長是由先進設備的可用性、精密設施、熟練的神經外科醫生和整容外科醫生的存在、手術設施的增加、對門診環境的偏好以及對醫療實踐的支持所推動的。看來美國是主要負責醫療費用框架。

美國承受著巨大的慢性病負擔，例如癌症、心血管疾病 (CVD) 和神經系統疾病。 美國疾病控制與預防中心 (CDC) 估計，2010 年至 2020 年期間，美國每年新增癌症病例數將增加 24%，男性超過 100 萬，女性約 21 例。據說每年有可能超過 900,000 人，這是一個 % 的增長。 這樣，由於慢性病的增加和治療的複雜性，使用手術顯微鏡的先進技術開始被採用。

技術先進的產品的推出推動了對手術顯微鏡的需求，因為它們提供了更好的照明源、更準確，並提供了根據程序的複雜性進行定制和技術集成的選項。支持 例如，2020 年 9 月，True Digital Surgery (TDS) 和 Aesculap Inc. 在美國推出了 Aesculap Aeos 機器人數字顯微鏡。 因此，此類技術先進產品的推出有望推動區域市場的增長。

但是，COVID-19 病例數量的增加可能會對北美手術顯微鏡市場的增長產生負面影響，因為它會影響大多數公司的供應鏈。 暫時停止使用手術顯微鏡等設備，以遏製手術設備的病毒污染。 然而，結腸鏡和內窺鏡等手術器械是外科手術不可或缺的一部分，因此預計不會產生長期影響。

手術顯微鏡市場競爭者分析

手術顯微鏡市場競爭激烈，由多家大型企業組成。 Alcon、Alltion（梧州）、ARI Medical Technology、Metall Zug（Haag-Streit）、Danaher Corporation、Olympus Corporation、Seiler Instrument Inc、Takagi Seiko、Topcon 和 Carl Zeiss AG 等公司佔據了相當大的市場份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 越來越多地採用微創手術
    • 老齡化社會的到來和慢性病的增加
    • 手術顯微鏡的技術進步
  • 市場製約因素
    • 缺乏熟練的專業人員
    • 成本高，接受度低
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 通過申請
    • 牙科
    • 婦科/泌尿科
    • 耳鼻喉科（耳鼻喉科）
    • 神經外科/脊柱外科
    • 腫瘤科
    • 眼科
    • 骨科和整形外科
    • 其他用途
  • 最終用戶
    • 醫院
    • 牙科診所
    • 其他最終用戶
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Alcon Inc.
    • Alltion（Wuzhou）Co. Ltd
    • ARI Medical Technology Co. Ltd
    • ATMOS MedizinTechnik GmbH & Co. KG
    • Avante Health Solutions
    • Carl Zeiss AG
    • HAAG-STREIT Surgical GmbH
    • Danaher Corporation（Leica Microsystems）
    • Metall Zug Group（Haag-Streit）
    • Olympus Corporation
    • Optofine Instruments Pvt. Ltd
    • Seiler Instrument Inc.
    • Synaptive Medical
    • Takagi Seiko Co. Ltd
    • Topcon Corporation

第7章 市場機會與今後動向

簡介目錄
Product Code: 61911

The surgical microscope market is expected to record a CAGR of 10.89% over the forecast period, 2022-2027.

As per the World Health Organization (WHO), COVID-19 is infectious, and most people infected by the virus experience mild to moderate respiratory illness. Due to the high transmission rate of COVID-19, countries like the United States have suffered and are continuing to bear a significant burden on their economies and healthcare systems. The country has been in lockdown, suspended trade with other countries, and implemented travel restrictions, leading to a decline in the market capitalization of major companies worldwide. However, the situation has improved gradually with an increase in the vaccination rate. The delay of elective procedures due to COVID-19-related measures has adversely affected the surgical microscopes market, especially in 2020, as only urgent surgeries were allowed. Most cardiac procedures were canceled or postponed due to the diversion of resources toward the COVID-19 infected patients. However, with the increasing vaccination rates, the number of surgeries performed also increased, significantly impacting the market. Operating theaters were temporarily converted to respiratory support units in regions with a high disease burden. Postoperative recovery rooms and intermediate care units were used as care units outside regular intensive care to manage sick patients affected by COVID-19. For instance, according to the study published in the British Journal of Surgery, in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed, thus indicating the negative impact of COVID-19 on the market studied.

Certain factors driving the market include the increasing adoption of minimally invasive surgeries, the rising geriatric population and burden of chronic diseases, and technological advancements in surgical microscopes.

The global population is aging rapidly due to reduced birth rates and increasing life expectancy. For instance, according to the United Nations' World Population Prospects for 2020, the number of people over 65 years may increase from 9.3% in 2020 to more than 16% by 2050. Hence, the prevalence of age-associated chronic diseases and subsequent surgical interventions increased, expanding the market.

Surgical microscopes have become a crucial tool for minimally invasive surgical procedures in dental surgery, otorhinolaryngology, neurosurgery, ophthalmic surgery, and cosmetic surgery. Technological advancements in the products have significantly improved vision, positioning, stability, sizing, and recording capabilities and helped in the integration of image-guided microscope systems for better outcomes.

A surgical microscope offers optimum lighting, 3D visualization, and magnification of deep surgical fields through small approaches. It also benefits surgeons by adjusting their posture while performing complicated and long procedures. These factors are anticipated to propel the market during the forecast period.

However, factors such as lack of skilled professionals and low acceptance due to high cost are likely to hamper the market's growth over the forecast period.

Surgical Microscopes Market Trends

The Gynecology and Urology Segment is Expected to Hold a Significant Market Share

The COVID-19 outbreak negatively impacted the gynecology and urological application segment. The pandemic has majorly impacted surgical services. As per the study titled "COVIDSurg Collaborative," in May 2020, approximately 2.5 million benign urological surgeries were canceled due to the COVID-19 outbreak. However, as elective surgeries and emergency surgical procedures are resuming, the demand for surgical microscopes for urological and gynecology conditions may increase.

The applications of surgical microscopes are wide, among which gynecological and urological applications are the most common, as these practices include many procedures. As the prevalence of urological and gynecological conditions is increasing worldwide, the significance of surgical microscopes is also increasing. For instance, urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all ages. According to the study titled "Epidemiology of urological infections: a global burden," World Journal of Urology, January 2020, about 150 million people get affected by community-acquired UTIs (CAUTIs). The rising prevalence of target disorders and the complexity of their treatment led to the adoption of advanced techniques involving surgical microscopes.

In gynecological and urological practices, microscopes are used for the detection of cancers, laser surgeries, and diagnostic procedures. The microscopes, like colonoscopy and endoscopy, give access to the inside of the bowel or colon and ease the surgery. Due to the increasing diseases associated with bowel movements, colonoscopy and endoscopy are widely used, which is expected to drive the overall market over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

The market growth in the region is vastly attributed to the United States due to the availability of highly advanced equipment, the presence of sophisticated facilities, skilled neurosurgeons and cosmetic surgeons, the increasing number of surgical facilities, the preference for outpatient settings, and the supportive reimbursement framework for medical treatments.

The burden of chronic illnesses, like cancer, cardiovascular diseases (CVD), and neurological diseases, is huge in the United States (US). The Centers for Disease Control and Prevention (CDC) estimates that, between 2010 and 2020, the number of new cancer cases in the country may increase by 24% in men to more than 1 million cases per year and by about 21% in women to more than 900,000 cases per year. Thus, the rising prevalence of chronic disorders and the complexity of their treatment have led to the adoption of advanced techniques that involve the use of surgical microscopes.

The introduction of technologically advanced products is boosting the demand for surgical microscopes as they offer better illumination sources, are more precise, and provide options for customization and technology integration based on the complexity of the procedures. For instance, in September 2020, True Digital Surgery (TDS) and Aesculap Inc. launched Aesculap Aeos Robotic Digital Microscope in the United States. Thus, such technologically advanced product launches are expected to boost the regional market's growth.

However, the rising number of COVID-19 cases may negatively impact the growth of the North American surgical microscopes market due to the affected supply chains of most companies. The usage of equipment like surgical microscopes was temporarily halted to curb the contamination of the virus through surgical equipment. However, as surgical instruments such as colonoscopes and endoscopes are essential components of surgical services, the impact is not expected to be long-term.

Surgical Microscopes Market Competitor Analysis

The surgical microscopes market is highly competitive and consists of several major players. Companies like Alcon, Alltion (Wuzhou) Co. Ltd, ARI Medical Technology Co. Ltd, Metall Zug (Haag-Streit), Danaher Corporation, Olympus Corporation, Seiler Instrument Inc., Takagi Seiko Co. Ltd, Topcon, and Carl Zeiss AG hold a substantial share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Adoption of Minimally Invasive Surgeries
    • 4.2.2 Rise in Geriatric Population and Burden of Chronic Diseases
    • 4.2.3 Technological Advancements in Surgical Microscopes
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 Low Acceptance Owing to High Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application
    • 5.1.1 Dentistry
    • 5.1.2 Gynecology and Urology
    • 5.1.3 Ear, Nose, and Throat (ENT)
    • 5.1.4 Neurosurgery and Spine Surgery
    • 5.1.5 Oncology
    • 5.1.6 Ophthalmology
    • 5.1.7 Plastic and Reconstructive Surgery
    • 5.1.8 Other Applications
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Dentist Clinics
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon Inc.
    • 6.1.2 Alltion (Wuzhou) Co. Ltd
    • 6.1.3 ARI Medical Technology Co. Ltd
    • 6.1.4 ATMOS MedizinTechnik GmbH & Co. KG
    • 6.1.5 Avante Health Solutions
    • 6.1.6 Carl Zeiss AG
    • 6.1.7 HAAG-STREIT Surgical GmbH
    • 6.1.8 Danaher Corporation (Leica Microsystems)
    • 6.1.9 Metall Zug Group (Haag-Streit)
    • 6.1.10 Olympus Corporation
    • 6.1.11 Optofine Instruments Pvt. Ltd
    • 6.1.12 Seiler Instrument Inc.
    • 6.1.13 Synaptive Medical
    • 6.1.14 Takagi Seiko Co. Ltd
    • 6.1.15 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS